Taxonomy and identification of the Burkholderia cepacia complex

Journal of Clinical Microbiology

Volumn 39, Issue 10, 2001, Pages 3427-3436

  Coenye, T ^a   Vandamme, P ^a   Govan, J R W ^a   Lipuma, J J ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM IDENTIFICATION; BURKHOLDERIA CEPACIA; CYSTIC FIBROSIS; DISEASE ASSOCIATION; GENOTYPE; NONHUMAN; PHENOTYPE; PHYLOGENY; PRIORITY JOURNAL; SHORT SURVEY; TAXONOMY;

BACTERIAL TYPING TECHNIQUES; BURKHOLDERIA CEPACIA; BURKHOLDERIA INFECTIONS; GENOTYPE; HUMANS; PHENOTYPE;

BACTERIA (MICROORGANISMS); BURKHOLDERIA; BURKHOLDERIA CEPACIA;

EID: 0034799341     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.39.10.3427-3436.2001     Document Type: Short Survey

References (123)

1. Burkholderia caribensis sp. nov., an exopolysaccharide-producing bacterium isolated from vertisol microaggregates in Martinique
2. Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden
3. Bacteraemia caused by non-aeruginosa Pseudomonas species in a cancer centre
4. Burkholderia cepacia genomovar III is a common plant-associated bacterium
5. Taxonomy of the aerobic pseudomonads: Pseudomonas cepacia, P. marginata, P. alliicola and P. caryophylli
6. Discrimination of Burkholderia multivorans and Burkholderia vietnamiensis from Burkholderia cepacia genomovars I, III, and IV by PCR
7. Phenotypic comparison between rhizosphere and clinical isolates of Burkholderia cepacia
8. Identification and characterization of a new plasmid carrying genes for degradation of 2:4-dichlorophenoxyacetate from Pseudomonas cepacia CSV90
9. Epidemiology of Pythium damping-off and Aphanomyces root rot of peas after seed treatment with bacterial agents for biological control
10. Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei-like species
11. Distinguishing species of the Burkholderia cepacia complex and Burkholderia gladioli by automated ribotyping
12. A medium selective for Pseudomonas cepacia
13. Sour skin, a bacterial rot of onion bulbs
14. Microbiology of sputum from patients at cystic fibrosis centers in the United States
15. Burkholderia cepacia and cystic fibrosis: Do natural environments present a potential hazard?
16. Detection of Pseudomonas (Burkholderia) cepacia using PCR
17. Comparative evaluation of selective media for isolation of Pseudomonas cepacia from cystic fibrosis patients and environmental sources
18. Infection with Burkholderia cepacia in cystic fibrosis: Outcome following lung transplantation
19. Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis
20. Description of Pandoraea gen. nov. with Pandoraea apista sp. nov., Pandoraea pulmonicola sp. nov., Pandoraea pmomenusa sp. nov., Pandoraea sputorum sp. nov. and Pandoraea norimbergensis comb. nov.
21. Classification of some Alcaligenes faecalis-like isolates from the environment and human clinical samples as Ralstonia gilardii sp. nov.
22. Burkholderia cocovenenans (van Damme et al. 1960) Gillis et al. 1995 and Burkholderia vandii Urakami et al. 1994 are junior subjective synonyms of Burkholderia gladioli (Severini 1913) Yabuuchi et al. 1993 and Burkholderia plantarii (Azegami et al. 1987) Urakami et al. 1994, respectively
23. Burkholderia fungorum sp. nov. and Burkholderia caledonica sp. nov., two new species isolated from the environment, animals and human clinical samples
24. Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients
25. Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates
26. Identification of Burkholderia species and genomovars from cystic fibrosis patients by AFLP fingerprinting
27. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia
28. Phenol and trichloroethylene degradation by Pseudomonas cepacia G4: Kinetics and interactions between substrates
29. A polyphasic approach towards the identification of strains belonging to Lactobacillus acidophilus and related species
30. Microbiology of airway disease in patients with cystic fibrosis
31. Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis
32. 2-fixing isolates from rice in Vietnam
33. Burkholderia cepacia - Friend and foe
34. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis patients
35. Microbial pathogenesis in cystic fibrosis: Mucoid Pseudomonas aeruginosa and Burkholderia cepacia
36. Burkholderia cepacia: Medical, taxonomic and ecological issues
37. Agricultural and medical microbiology: A time for bridging gaps
38. A selective medium for enumeration and recovery of Pseudomonas cepacia biotypes from soil
39. Suppression of pre- and postemergence damping-off in corn by Burkholderia cepacia
40. Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium
41. Comparison of isolation media for recovery of Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis
42. Biochemical and molecular approaches for determining genomovar status of the Burkholderia cepacia complex
43. Burkholderia (Pseudomonas) cepacia as a cause of brain abscesses secondary to chronic suppurative otitis media
44. Agricultural use of Burkholderia (Pseudomonas) cepacia: A threat to human health?
45. High-resolution genotypic analysis of the genus Aeromonas by AFLP fingerprinting
46. Relevance of nucleic acid amplification techniques for diagnosis of respiratory tract infections in the clinical laboratory
47. Pseudomonas cepacia infection in cystic fibrosis: An emerging problem
48. Evaluation of the DNA fingerprinting method AFLP as a new tool in bacterial taxonomy
49. Proposal of a new species Pseudomonas kingii
50. An outbreak of Burkholderia cepacia bacteremia in hemodialysis patients: An epidemiologic and molecular study
51. Polymerase chain reaction for the detection of Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia in sputum of patients with cystic fibrosis
52. Genus Alcaligenes
53. Recent changes in the classification of the pseudomonads: An overview
54. Biodegradation of 2:4,5-trichlorophenoxyacetic acid by a pure culture of Pseudomonas cepacia
55. Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative, nonfermenting bacilli recovered from patients with cystic fibrosis
56. High-resolution genomic fingerprinting of Campylobacter jejuni and Campylobacter coli by analysis of amplified fragment length polymorphisms
57. Degradation of trichloroethylene by Pseudomonas cepacia G4 and the constitutive mutant strain G4 5223 PR1 in aquifer microcosms
58. Chronic granulomatous disease presenting in childhood with Pseudomonas cepacia septicaemia
59. Marked phenotypic variability in Pseudomonas cepacia isolated from a patient with cystic fibrosis
60. Identification of aquatic Burkholderia (Pseudomonas) cepacia by hybridization with species-specific rRNA gene probes
61. Predictive 5-year survivorship model of cystic fibrosis
62. Burkholderia cepacia: Management issues and new insights
63. Burkholderia cepacia epidemiology and pathogenesis: Implications for infection control
64. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis
65. Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients
66. Commercial use of Burkholderia cepacia
67. Inapparent transmission of Pseudomonas (Burkholderia) cepacia among patients with cystic fibrosis
68. Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis
69. Comparison of different PCR approaches for characterization of Burkholderia (Pseudomonas) cepacia isolates
70. DNA-based diagnostic approaches for the identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III
71. Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex
72. Enhanced host defense after gene transfer in the murine p47phox-deficient model of chronic granulomatous disease
73. Molecular epidemiology: Application of contemporary techniques to the typing of microorganisms
74. Pseudomonas cepacia suppression of sunflower wilt fungus and role of antifungal compounds in controlling the disease
75. Misidentification of Burkholderia cepacia in U.S. cystic fibrosis treatment centers: An analysis of 1051 recent sputum isolates
76. Transmission of Pseudomonas cepacia among cystic fibrosis patients
77. A group of pseudomonads able to synthesize poly-β-hydroxybutyric acid
78. Development of a PCR probe test for identifying Pseudomonas aeruginosa and Pseudomonas (Burkholderia) cepacia
79. Principles and applications of methods for DNA-based typing of microbial organisms
80. AL (nom. cons. opin. 5, Jud. Comm. 1952, 237)
81. Pseudomonas cepacia, sp. nov., nom. rev
82. Nucleic acid homologies in the genus Pseudomonas
83. Biological control of Pythium damping-off and Aphanomyces root rot of peas by application of Pseudomonas cepacia or P. fluorescens to seed
84. Acquisition of Pseudomonas cepacia at summer camps for patients with cystic fibrosis
85. Comparison of AFLP and rep-PCR genomic fingerprinting with DNA-DNA homology studies: Xanthomonas as a model system
86. The fatty acids of Pseudomonas multivorans (Pseudomonas cepacia) and Pseudomonas kingii
87. Amplified-fragment length polymorphism analysis: The state of an art
88. Differentiation of Burkholderia species by PCR-restriction fragment length polymorphism analysis of the 16S rRNA gene and application to cystic fibrosis isolates
89. Utility of commercial systems for identification of Burkholderia cepacia complex from cystic fibrosis sputum culture
90. Impact of microbiology practice on cumulative prevalence of respiratory tract bacteria in patients with cystic fibrosis
91. Multi-resistance isolates possessing characteristics of both Burkholderia (Pseudomonas) cepacia and Burkholderia gladioli from patients with cystic fibrosis
92. Emendation of the description of Pseudomonas cepacia Burkholder (synonyms: Pseudomonas multivorans Stanier et al., Pseudomonas kingae Jonsson; EO-1 Group)
93. Approved lists of bacterial names
94. Pseudomonas cepacia infection in cystic fibrosis
95. Identification of Pseudomonas cepacia Burkholder and its synonymy with Pseudomonas kingii Jonsson
96. Infection with Pseudomonas cepacia in chronic granulomatous disease: Role of nonoxidative killing by neutrophils in host defense
97. The aerobic pseudomonads: A taxonomic study
98. Grouping of plant-pathogenic and some other Pseudomonas spp. by using cellular fatty acid profiles
99. + Pseudomonas (Burkholderia) cepacia causing CF center epidemics in North America and Britain
100. Molecular characterisation of rhizosphere and clinical isolates of Burkholderia cepacia
101. Oligonucleotide primers designed to differentiate pathogenic pseudomonads on the basis of the sequence of genes coding for 16S-23S rRNA internal transcribed spacers
102. Transfer of Pseudomonas plantarii and Pseudomonas glumae to Burkholderia as Burkholderia spp. and description of Burkholderia vandii sp. nov.
103. Taxonomic note: A pragmatic approach to the nomenclature of phenotypically similar genomic groups
104. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.
105. Identification and population structure of Burkholderia stabilis sp. nov. (formerly Burkholderia cepacia genomovar IV)
106. Polyphasic taxonomy, a consensus approach to bacterial systematics
107. An outbreak of Burkholderia cepacia with septicemia on a cardiology ward
108. Identification of Burkholderia spp. in the clinical microbiology, laboratory: Comparison of conventional and molecular methods
109. Burkholderia graminis sp. nov., a rhizospheric Burkholderia species, and reassesment of [Pseudomonas] phenazinium, [Pseudomonas] pyrrocinia and [Pseudomonas] glathei as Burkholderia
110. Burkholderia cepacia - Friend or foe?
111. Acinetobacter, Alcaligenes, Moraxella, and other nonfermentative gram-negative bacteria
112. Application of cellular fatty acid analysis
113. Selective and differential medium for the recovery of Pseudomonas cepacia from the respiratory tract of patients with cystic fibrosis
114. Identification of members of the Burkholderia cepacia complex by species-specific PCR
115. Species-specific PCR as a tool for the identification of Burkholderia gladioli
116. Nosocomial acquisition of Burkholderia gladioli in patients with cystic fibrosis
117. Isolation and characterisation of Burkholderia norimbergensis sp. nov., a mildly alkaliphilic sulfur oxidizer
118. Burkholderia uboniae sp. nov., L-arabinose asimilating but different from Burkholderia thailandensis and Burkholderia vietnamiensis
119. Proposal of Burkholderia gen. nov.; and transfer of seven species of the Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov.
120. Transfer of two Burkholderia and an Alcaligenes species to Ralstonia gen. nov.: Proposal of Ralstonia pickettii (Ralston, Palleroni and Doudoroff 1973) comb. nov., Ralstonia solanacearum (Smith 1896) comb. nov. and Ralstonia eutropha (Davis 1969) comb. nov.
121. Multilocus isoenzyme diversity among strains of Pseudomonas cepacia isolated from decayed onions, soils, and clinical sources
122. Burkholderia kururiensis sp. nov., a trichloroethylene (TCE)-degrading bacterium isolated from an aquifer polluted with TCE
123. Phylogenetic evidence for the transfer of Pseudomonas cocovenenans (van Damme et al. 1960) to the genus Burkholderia as Burkholderia cocovenenans (van Damme et al. 1960) comb. nov.